Targeted Oxygenation in the Resuscitation of Premature Infants: Effects on Developmental Outcome – the TORPIDO2 Study.
- National Health and Medical Research Council (NHMRC), 2015.
- Principal investigator
- Dr. Máximo Vento
The TORPIDO 2 study is a pragmatic, randomised controlled trial (RCT) in infants between 23 weeks and 28 weeks 6 days gestation which aims to test one primary and two secondary hypotheses; that, compared with starting resuscitation with 60% oxygen and a targeted oxygen saturation (SpO2) strategy, starting resuscitation with room air (21% oxygen) and the same targeted SpO2 strategy will improve the survival without major disability at 2 years corrected for gestation.